Inhibition of the tissue factor/factor VIIa complex — Lead optimisation using combinatorial chemistry

[1]  S. Nikam,et al.  New Synthesis of Substituted Benzylamines. Novel Application of the Mitsunobu Reaction To Convert Substituted Benzyl Alcohols to Amines , 1997 .

[2]  K. Mann,et al.  Kinetics of human factor VII activation. , 1996, Biochemistry.

[3]  S. Kaldor,et al.  Solid phase synthesis of hydantoins using a carbamate linker and a novel cyclization / cleavage step , 1996 .

[4]  M. Lebl,et al.  Polymer-Supported Mitsunobu Ether Formation and its Use in Combinatorial Chemistry , 1995 .

[5]  S. Hanson,et al.  Antithrombotic Benefits and Hemorrhagic Risks of Direct Thrombin Antagonists , 1995, Thrombosis and Haemostasis.

[6]  K. Chapman,et al.  Solid phase synthesis of aryl ethers via the mitsunobu reaction , 1995 .

[7]  S. Katakura,et al.  Dibasic (amidinoaryl)propanoic acid derivatives as novel blood coagulation factor Xa inhibitors. , 1994, Journal of medicinal chemistry.

[8]  P. Neuenschwander,et al.  Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism. , 1993, The Journal of biological chemistry.

[9]  F. Albericio,et al.  Automated allyl cleavage for continuous-flow synthesis of cyclic and branched peptides. , 1993, Analytical biochemistry.

[10]  G. Pandey,et al.  Ag(I)F as one electron oxidant for promoting sequential double desilylation : An ideal approach to non-stabilized azomethine ylides for the rapid construction of 1-azabicyclo (m:3:0) alkanes , 1993 .

[11]  R. Bertina,et al.  The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII. , 1990, The Biochemical journal.

[12]  T. Yaegashi,et al.  Synthesis and structure-activity study of protease inhibitors. IV. Amidinonaphthols and related acyl derivatives. , 1985, Chemical and pharmaceutical bulletin.

[13]  H. Kunz,et al.  The Allyloxycarbonyl (Aloc) Moiety—Conversion of an Unsuitable into a Valuable Amino Protecting Group for Peptide Synthesis† , 1984 .

[14]  R. B. Merrifield,et al.  Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. , 1981, Analytical biochemistry.